How does AP-1 mechanistically regulate chromatin accessibility to expose IRF2BP2 binding sites?

Open a bounty challenge Fund this gap and accept submissions. SPEC-033.

Composite

—

Novelty

—

Mechanistic

—

Druggability

—

Priority

83%

Importance

82%

Tractability

85%

Market price

50%

Description

The abstract states that AP-1 ‘plays a pivotal role in shaping the chromatin accessibility landscape’ to expose IRF2BP2 binding sites, but the specific molecular mechanisms are not explained. Understanding this chromatin remodeling process is crucial for targeting this pathway therapeutically in neuroblastoma.

Gap type: unexplained_observation Source paper: Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation. (2024, Neuro-oncology, PMID:38864832)